期刊文献+

苯磺酸左旋氨氯地平血药浓度的LC-MS/MS法测定及其人体内手性转化可能性考察 被引量:3

Determination of levamlodipine concentration by LC-MS/MS and its chiral transformation potential in human plasma
下载PDF
导出
摘要 目的建立LC-MS/MS法测定人血浆中左旋氨氯地平血药浓度并进行体内手性转化可能性考察。方法以氯氮为内标,采用CHIRAL-AGP柱(150.0mm×4.0mm,5μm)对氨氯地平消旋体进行分离手性对映体,流动相为10mmol/L乙酸铵缓冲液(pH 4.38)-异丙醇(982,V/V);选择固相萃取法提取10例健康男性受试者单次口服苯磺酸左旋氨氯地平片2.5mg后的血浆样品,大气压化学电离源(APCI)结合正离子MRM扫描分析测定人体内S-(-)-氨氯地平浓度,其中氨氯地平和内标离子对分别是m/z 409.0→237.9和m/z 300.0→282.0。结果 S-(-)-/R-(+)-氨氯地平对映体血药浓度在0.103 1~20.62μg/L范围内线性关系良好(r=0.999 8,r=0.999 7),绝对回收率大于70.0%,相对回收率均在85.0%~115.0%范围内,日内和日间RSD均小于15.0%。10例健康男性受试者单剂量口服苯磺酸左旋氨氯地平片2.5mg后体内不同时间点血浆样品均未检测到R-(+)-氨氯地平对映体,S-(-)-氨氯地平在健康男性受试者体内的药代动力学参数t1/2为(42.77±8.08)h,Cmax为(3.06±0.51)μg/L,tmax为(6.3±1.0)h,MRT为(69.25±8.04)h,AUC0-144为(176.20±31.89)h.μg.L-1,AUC0-∞为(197.92±37.54)h.μg.L-1。结论本方法选择性强,灵敏度高,无杂质干扰,精密度好,成功地应用于苯磺酸左旋氨氯地平人体药代动力学分析,并证实S-(-)-氨氯地平对映体在健康男性受试者体内未发现其手性转化。 Objective To determine S-(-)-amlodipine level in human plasma by LC-MS/MS method, and to investigate its chiral transformation potential in healthy male volunteers. Methods The separation of amlodipine was performed by CHIRAL-AGP analytical column (150.0 mm×4.0 mm, 5 μm) with 10 mmol/L acetate buffer (pH 4.38)-2-propanol (98 : 2, V/V) as the mobile phase and chlordiazepoxide as the internal standard. The plasma S-(-) amlodipine was extracted with solid phase extraction in ten healthy male volunteers at different time points after oral test (2.5 mg). Atmospheric-pressure chemical ionization (APCI) and multiple reaction monitoring (MRM) were used with positive ion scans, and the mass transition pairs of m/z 409.0→237.9 and m/z 300.0→282.0 were used to detect amlodipine and internal standard, respectively. Results The linear calibration curve of each enantiomer of amlodipine showed excellent correlation over the range of 0. 1031 ~g/L (20.62μg/ L(r=0. 999 8, r=0. 999 7). The absolute recovery was more than 70.0%, the relative recoveries were 85.0%-115.0%, and intra-run and inter-run relative standard deviation (RSD) were less than 15.0%. No R-(--)-amlodipine was detected in the plasma of ten healthy male volunteers at different time points after single oral test. The main pharmacokinetic parameters of 8- (--)-amlodipine in healthy male volunteers were as follows:tl/2was (42.77±8.08) h, Cmaxwas (3. 06-t-0. 51) /~g/L, tmax was (6.3±1.0) h, MRTwas (69.25±8.04) h, AUC0-144 was (176.20±31.89) h·μg· L^-1, and AUC0→was (197.92~37.54) h ·μg · L^-1. Conclusion The present method is highly selective, sensitive, accurate and with no endogenous interference for pharmacokinetic study. R-(+)-amlodipine is not found in the plasma, indicating that there is no chiral transformation in healthy male volunteers.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2012年第7期763-769,共7页 Academic Journal of Second Military Medical University
基金 国家"重大新药创制"科技专项(2009ZX09301-011-07)~~
关键词 氨氯地平 液相色谱-串联质普法 手性拆分 药代动力学 手性转化 amtodipine liquid chromatography-tandem mass spectrometry chiral separation pharmacokinetics chiraltransformation
  • 相关文献

参考文献10

二级参考文献85

共引文献113

同被引文献23

  • 1程艳玲,仇士东.左旋氨氯地平的临床药理及临床应用[J].齐鲁药事,2006,25(10):612-614. 被引量:9
  • 2陈丽佳,吴伟明.反相高效液相色谱法测定人血浆苯磺酸左旋氨氯地平浓度[J].医药导报,2006,25(12):1256-1259. 被引量:5
  • 3Mega JL,Close SL,Wiviott SD,et al.Cytochrome p-450 polymorphisms and response to clopidogrel[J].N Engl J Med,2009,360(4):354. 被引量:1
  • 4Xia ZL,Wang ML,Zou SL,et al.Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes[J].Eur J Drug Metab Pharmacokinet,2012,37(3):211. 被引量:1
  • 5Zahno A,Brecht K,Bodmer M,et al.Effects of drug interactionson biotransformation and antiplatelet effect of clopidogrel in vitro[J].Br J Pharmacol,2010,161(2):393. 被引量:1
  • 6Kazui M,Nishiya Y,Ishizuka T,et al.Identification of the human cytochrome P450enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite[J].Drug Metab Dispos,2010,38(1):92. 被引量:1
  • 7Richter T,Mürdter TE,Heinkele G,et al.Inhibition of human CYP2B6 by clopidogrel and ticlopidine[J].J Pharmacol Exp Ther,2004,308(1):189. 被引量:1
  • 8Krippendorff BF,Lienau P,Reichel A,et al.Optimizing classification of drug-drug interaction potential for CYP450 iso-enzymes inhibition assays in early drug discovery[J].J Biomol Screen,2007,12(1):92. 被引量:1
  • 9Olesen JB,Gislason GH,Charlot MG,et al.Calciumchannel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction[J].Journal of the American College of Cardiology,2011,57(4):409. 被引量:1
  • 10Siller-Matula JM,Lang I,Christ G,et al.Calcium-channel blockers reduce the antiplatelet effect of clopidogrel[J].Journal of the American College of Cardiology,2008,52(19):1 557. 被引量:1

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部